Global Fund – GeneXpert
Overview
WDI is conducting a review for the Global Fund with the goal of leveraging ongoing Diagnostic Network Optimization initiatives, as well as performance metrics in selected countries and other existing data sources on investments in GeneXpert technologies, to support robust cross-country comparisons, and develop a conceptual framework for addressing cost efficiency questions for multi-disease integrated testing platforms. The work entails developing a Theory of Change that recognizes the complex relationships between cost-efficiencies and other components of the Global Fund’s Value for Money concept, including effectiveness, equity and sustainability.